Literature DB >> 10872327

Latent and lytic cycle promoters of Epstein-Barr virus.

P J Farrell1, A Bankier, C Séguin, P Deininger, B G Barrell.   

Abstract

Four RNA polymerase II promoters have been mapped in the DNA sequence of the EcoRI-H and -Dhet fragments of B95-8 Epstein-Barr virus. RNAs transcribed from three of these promoters are dramatically induced by treatment of B95-8 cells with 12-O-tetradecanoylphorbol-13-acetate (TPA). The other promoter is active with or without TPA treatment of the cells and is thus active in the latent virus cycle. Deletion mapping suggests that DNA sequence homologies between some of the promoters lie in the same region as essential upstream promoter elements.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 10872327      PMCID： PMC555279          DOI： 10.1002/j.1460-2075.1983.tb01588.x

Source DB:  PubMed          Journal:  EMBO J        ISSN： 0261-4189            Impact factor:   11.598


  15 in total

1.  Spliced early mRNAs of simian virus 40.

Authors:  A J Berk; P A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

2.  Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes.

Authors:  G Miller; T Shope; H Lisco; D Stitt; M Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1972-02       Impact factor: 11.205

3.  Accumulation of an mRNA and protein in interferon-treated Ehrlich ascites tumour cells.

Authors:  P J Farrell; R J Broeze; P Lengyel
Journal:  Nature       Date:  1979-06-07       Impact factor: 49.962

4.  Epstein-Barr virus RNA. VIII. Viral RNA in permissively infected B95-8 cells.

Authors:  M Hummel; E Kieff
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

5.  Molecular cloning of the complete Epstein-Barr virus genome as a set of overlapping restriction endonuclease fragments.

Authors:  J R Arrand; L Rymo; J E Walsh; E Björck; T Lindahl; B E Griffin
Journal:  Nucleic Acids Res       Date:  1981-07-10       Impact factor: 16.971

6.  Promoter sequences of eukaryotic protein-coding genes.

Authors:  J Corden; B Wasylyk; A Buchwalder; P Sassone-Corsi; C Kedinger; P Chambon
Journal:  Science       Date:  1980-09-19       Impact factor: 47.728

7.  Mapping of polypeptides encoded by the Epstein-Barr virus genome in productive infection.

Authors:  M Hummel; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

8.  Characterization of the major Epstein-Barr virus-specific RNA in Burkitt lymphoma-derived cells.

Authors:  J R Arrand; L Rymo
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

9.  DNA-dependent transcription of adenovirus genes in a soluble whole-cell extract.

Authors:  J L Manley; A Fire; A Cano; P A Sharp; M L Gefter
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

10.  Selective and accurate initiation of transcription at the Ad2 major late promotor in a soluble system dependent on purified RNA polymerase II and DNA.

Authors:  P A Weil; D S Luse; J Segall; R G Roeder
Journal:  Cell       Date:  1979-10       Impact factor: 41.582
View more
  10 in total

1.  Lytic cycle gene regulation of Epstein-Barr virus.

Authors:  Wolfgang Amon; Ulrich K Binné; Helen Bryant; Peter J Jenkins; Claudio Elgueta Karstegl; Paul J Farrell
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

2.  Epstein-Barr virus gene expression in P3HR1-superinfected Raji cells.

Authors:  M Biggin; M Bodescot; M Perricaudet; P Farrell
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

3.  Latent and viral replicative transcription in vivo from the BamHI K fragment of Epstein-Barr virus DNA.

Authors:  R Weigel; G Miller
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

4.  Two related but differentially expressed potential membrane proteins encoded by the EcoRI Dhet region of Epstein-Barr virus B95-8.

Authors:  G S Hudson; P J Farrell; B G Barrell
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

5.  Construction and use of cDNA clones for the mapping and identification of Epstein-Barr virus early P3HR-1 mRNAs.

Authors:  E Manet; A Chevallier; C X Zhang; T Ooka; P Chavrier; J Daillie
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

6.  An ATF/CRE element mediates both EBNA2-dependent and EBNA2-independent activation of the Epstein-Barr virus LMP1 gene promoter.

Authors:  A Sjöblom; W Yang; L Palmqvist; A Jansson; L Rymo
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

7.  Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein.

Authors:  S Fennewald; V van Santen; E Kieff
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

8.  Structure and evolution of two related transcription units of Epstein-Barr virus carrying small tandem repeats.

Authors:  G Laux; U K Freese; G W Bornkamm
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

9.  The LMP1 oncogene of EBV activates PERK and the unfolded protein response to drive its own synthesis.

Authors:  Dong Yun Lee; Bill Sugden
Journal:  Blood       Date:  2007-11-27       Impact factor: 22.113

10.  A spliced Epstein-Barr virus gene expressed in immortalized lymphocytes is created by circularization of the linear viral genome.

Authors:  G Laux; M Perricaudet; P J Farrell
Journal:  EMBO J       Date:  1988-03       Impact factor: 11.598
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.